OEM Wearable TENS Period Pain Relief Unit | Dysmenorrhea Neurostimulator | TOP-RANK
B2B contract manufacturing of wearable TENS period pain relief devices for primary dysmenorrhea and chronic pelvic pain. Features dual isolated constant-current channels, T10–L1/S2–S4 dermatomal frequency sweeps (80–120 Hz), sub-0.005 uC net DC offset, 80V dynamic compliance rail, and custom ergonomic pelvic butterfly electrodes.
Product Overview
The wearable TENS period pain relief device functions as an electro-analgesic generator engineered for primary dysmenorrhea, secondary pelvic congestion, and endometriosis-associated pain. The system targets visceral pain pathways originating from uterine hyperactivity: elevated local concentrations of prostaglandin F2-alpha (PGF2α) and prostaglandin E2 (PGE2) induce violent myometrial vasospasms, compressing intramural uterine arterioles and triggering ischemic nociceptive firing. These visceral pain impulses travel along sympathetic splanchnic afferents entering the spinal cord at dermatomes T10–L1 (referred to the suprapubic abdomen and lower back) and parasympathetic pelvic nerves at S2–S4 (referred to the sacrum and upper thighs).
Standard consumer-grade menstrual stimulators consistently exhibit three hardware and electrophysiological failure modes during continuous wear:
- Focal Current Crowding from Suprapubic Contour Delamination: The lower abdominal stratum corneum is exceptionally thin (10 to 15 um) and subject to constant dynamic flexion during sitting and bending. Rigid, mass-market electrode pads peel away at the margins under body heat and sweat, shrinking the effective conductive area from 20 cm² down to less than 2 cm². Open-loop stimulators continue delivering full output current into the remaining contact point, driving local current density past 2.0 mA/cm² and causing painful micro-arc burns.
- Galvanic Dermal Erythema from Asymmetric DC Drift: Menstrual pain protocols demand continuous wear for 4 to 8 hours daily. Low-cost stimulators built with passive pull-down output stages exhibit switching asymmetry that leaks direct current (DC). This unidirectional charge accumulation shifts local skin pH beneath the pads (acidic build-up at the positive terminal, alkaline pooling at the negative terminal), inducing chemical burns, intense pruritus, and contact dermatitis on sensitive pelvic skin.
- Open-Loop Voltage Clamping Across Fluctuating Dermal Impedance: During acute menstrual cramping, pelvic dermal impedance shifts rapidly between 400 Ohm (during episodes of cold sweats and vasomotor flushing) and 2,500 Ohm (on cool, dry skin). Budget constant-voltage stimulators either deliver decaying, sub-therapeutic current when impedance rises, or discharge sudden, painful current spikes when perspiration collapses tissue resistance.
This wearable neurostimulation platform utilizes dual isolated constant-current driver stages backed by an active 80V dynamic compliance rail. The microprocessor executes an automated 80 Hz to 120 Hz dermatomal frequency sweep to suppress Aβ nerve fiber accommodation, paired with series-stacked ceramic DC-blocking capacitors that restrict net DC offset below 0.005 uC per cycle. The discrete, lightweight console interfaces with custom-molded, ultra-thin hydrogel butterfly patches designed for continuous, discreet undergarment wear. We contract-manufacture this platform for women's health medical brands, DTC wellness hardware companies, and clinical physical therapy distributors globally.
Technical & Engineering Description
The industrial manufacture of the wearable TENS period pain relief unit executes inside ISO 13485-certified Class 8 cleanrooms utilizing multi-layer high-density SMT lines. The electronics are assembled on a rigid-flex 4-layer FR-4 printed circuit board (PCB) to minimize vertical footprint while physically separating high-voltage boost stages from sensitive digital control elements.
The power conversion architecture incorporates an active, high-frequency inductive DC-DC boost converter operating at 300 kHz. Driven by an ultra-low-power 32-bit ARM Cortex-M0+ microcontroller, the boost stage elevates the 3.7V lithium-polymer cell voltage into a dynamically scalable 80V compliance rail. A closed-loop sensing circuit continuously monitors output current across 0.1% tolerance current shunts at a 200 kHz sampling frequency. When cutaneous impedance shifts across the suprapubic area (from 500 Ohm to 2,500 Ohm), firmware adjusts boost PWM duty cycles within 25 microseconds, holding the target therapeutic milliampere output constant.
The output driver stage utilizes four low-threshold N-channel power MOSFETs configured in a full H-bridge per channel. To eliminate direct-current leakage, each bridge output terminal is wired in series with a 100V-rated high-frequency ceramic capacitor (X7R dielectric). The firmware executes an active charge-balancing algorithm: the primary therapeutic negative pulse is immediately countered by a low-amplitude, prolonged positive recovery phase possessing an identical volt-second integral. This reduces net DC leakage below 0.005 uC per cycle, preventing galvanic ion accumulation and chemical skin damage.
The housing is molded from medical-grade polycarbonate-ABS alloy with a soft-touch matte finish. The patient interface utilizes proprietary double-wing butterfly electrode pads: a 0.8 mm thick closed-cell cross-linked polyethylene (PE) foam backing laminated with screen-printed carbon-silver conductive pathways, coated with an isotonic polyacrylate hydrogel (caliper 0.80 mm to 1.00 mm). The hydrogel is compounded with a balanced ratio of pharmaceutical-grade polyols and water to maintain a 90-degree peel adhesion between 3.8N and 5.2N / 25mm on abdominal skin.
Every production unit undergoes 100% automated test equipment (ATE) verification across an anatomical load matrix (300, 700, 1,200, and 2,500 Ohm in parallel with 0.1 uF). Testing validates pulse rise times (tr < 1.5μs), phase charge symmetry, and the 15-millisecond automatic shutoff response upon electrode detachment. The minimum contract manufacturing order is 5,000 units.
Key Features
-
Dermatomal Gating Frequency Sweeps (T10–L1 & S2–S4 Presynaptic Visceral Pain Inhibition)
Myometrial ischemic contractions transmit visceral pain through sympathetic afferents terminating in the dorsal horn of spinal cord segments T10 through L1, and parasympathetic afferents terminating in segments S2 through S4. Generic single-frequency stimulators (such as continuous 100 Hz units) quickly fail because mechanoreceptive axons undergo rapid adaptation: voltage-gated sodium channels along the axon become inactive, reducing the inhibitory bombardment on dorsal horn pain transmission (T) cells. Our device resolves this through an algorithmic dermatomal frequency sweep. The microprocessor sweeps pulse frequency between 80 Hz and 120 Hz across continuous 4-second cycles while modulating phase duration between 100 us and 180 us. The moving frequency spectrum recruits non-nociceptive Aβ sensory fibers in dermatomes T10–L1 (suprapubic skin) and S2–S4 (sacral region), maintaining continuous presynaptic inhibition in the substantia gelatinosa without allowing the neural pathway to adapt to the stimulus.
-
Sub-0.005 uC Charge-Neutralized Symmetrical Biphasic Output (Preventing Chemical Burns on Thin Suprapubic Dermis)
The skin over the suprapubic and pelvic regions is thin and prone to barrier breakdown: prolonged direct-current leakage causes rapid electrochemical injury. In conventional massagers with imperfect output symmetry, timing mismatches in low-cost driver switches leak direct current into the skin. During 4 to 8 hours of continuous wear under tight clothing, this net DC bias drives directional ion migration, shifting local pH below 3.5 at the anode and above 10.0 at the cathode, producing severe chemical erythema and skin breakdown. We resolve this by implementing an active H-bridge commutation sequence paired with series ceramic DC-blocking capacitors. Every negative stimulating pulse is paired with an active, polarity-reversed positive recovery pulse of equal charge area (∫ ipos dt = ∫ ineg dt). The series capacitors block continuous DC leakage, keeping net direct current strictly below 0.005 uC per cycle. The electrode-skin boundary remains electrochemically neutral across 8 hours of uninterrupted daily wear, eliminating chemical burns and post-treatment contact redness.
-
Soft-Start Ramp & Dynamic 80V Compliance Voltage Tracking (Eliminating Power-On Jolt and Impedance-Collapse Surges)
Menstrual cramping frequently causes sudden autonomic reactions, including cold sweats and rapid vasomotor dilation, dropping local skin resistance from 2,000 Ohm down to 500 Ohm in minutes. In constant-voltage stimulators, this resistance collapse causes current to spike into painful ranges. Furthermore, sudden power-on step changes in current trigger reflex muscle contractions, distressing patients. Our platform incorporates a digital soft-start ramping engine that steps current up gradually from 0.0 mA to the target amplitude over 1.5 seconds whenever the device powers on or changes modes. In parallel, a 200 kHz closed-loop sensing circuit tracks load impedance in real time. If the patient perspires and impedance collapses, the active 80V boost rail steps down its compliance voltage within 25 microseconds, holding current to the user's selected milliampere setting. If an electrode pad begins to detach (dR/dt > 800Ωms), the circuit automatically clamps output to zero within 15 microseconds, preventing current surges and micro-arcing.
Applications
Hospital Gynecology & Outpatient Dysmenorrhea Programs
Non-pharmacological prescription neurostimulation therapy for primary dysmenorrhea and adolescent menstrual cramping, providing rapid pain relief without non-steroidal anti-inflammatory drug (NSAID) gastrointestinal side effects.
Endometriosis & Chronic Pelvic Pain Management Centers
Long-duration at-home neurostimulation prescribed for refractory pelvic pain, deep dyspareunia, and adenomyosis-associated chronic cramping, enabling continuous ambulatory pain control during menstrual cycles.
Consumer Feminine Wellness & DTC Brand Channels
Compact, wearable neurostimulation devices engineered for private-label brand deployment, featuring ergonomic packaging and custom-colored enclosures for active professional and collegiate lifestyles.
OEM & Private Label
-
Chassis Miniaturization, Custom Butterfly Tooling & Discreet Packaging : We provide turnkey contract manufacturing for miniaturized wearable enclosures (circular pucks, curved teardrop pods) featuring magnetic snap docks, ultra-thin profiles (<11 mm), and soft-touch silicone coatings in custom brand Pantone colors. We develop custom die-cut tooling for split-wing butterfly hydrogel pads tailored to lower abdominal and lumbar sacral contours. Secondary packaging options include discreet, premium rigid gift boxes, magnetic travel cases with integrated USB-C charging cradles, and hermetically sealed replacement hydrogel pad blister multi-packs.
-
Two-Center Supply Chain Mechanics : High-precision SMT placement, ARM firmware burning, custom hydrogel continuous slot-die coating, and functional board testing execute natively inside our primary China facility. Mechanical chassis injection molding, lithium-polymer cell ultrasonic welding, final enclosure assembly, 24-hour burn-in stress calibration, cleanroom blister packaging, and ocean container palletization route through our Vietnam hub, shielding international B2B buyers from regional medical device tariffs and Section 301 duties.
Certifications
-
ANSI/AAMI NS4 & IEC 60601-2-10 Stringent Compliance : Production master units undergo comprehensive testing in accredited independent laboratories confirming compliance with ANSI/AAMI NS4 (Transcutaneous electrical nerve stimulators), IEC 60601-1 (Class II, Type BF applied parts), IEC 60601-1-2 (EMC Class B home healthcare limits), and IEC 60601-2-10. Output current ceilings (<60 mA peak), maximum phase energy limits (<300 mJ into 1,000 Ohm), and the 15-millisecond open-circuit cutoff response are interlocked in hardware.
-
ISO 10993 Comprehensive Dermal Biocompatibility : Direct skin-contact hydrogels, conductive inks, and foam adhesives undergo batch validation in accredited testing laboratories confirming compliance with ISO 10993-5 (In Vitro Cytotoxicity Grade 0), ISO 10993-10 (Skin Sensitization: 0% allergic response), and ISO 10993-23 (Primary Dermal Irritation Index = 0.0). The complete assembly is 100% natural rubber latex-free, phthalate-free, and solvent-free.
-
MDSAP & ISO 13485 Certified Manufacturing Oversight : Surface-mount assembly lines, ultrasonic welding bays, and packaging decks operate strictly under certified ISO 13485:2016 and MDSAP regulatory frameworks (covering US FDA 21 CFR 820, Health Canada, TGA Australia). Unbroken electronic Device History Records (DHR) log every discrete power MOSFET, transformer, battery cell lot, and packaging seal integrity test from incoming inspection to outbound shipping.
Technical FAQ
Q: Why does standard 100 Hz fixed-frequency TENS lose analgesic efficacy against primary dysmenorrhea within 20 minutes, and how does the 80–120 Hz dermatomal modulation sustain presynaptic gating?
A: Conventional TENS operates on Melzack and Wall's Gate Control Theory: non-nociceptive inputs from large-diameter myelinated Aβ sensory fibers stimulate inhibitory interneurons within the substantia gelatinosa of the spinal dorsal horn, blocking ascending C-fiber pain transmission. When stimulated with an unvarying, static frequency (e.g., constant 100.0 Hz), axonal membrane mechanics trigger sensory adaptation: voltage-gated sodium channels (Nav 1.6) enter an extended inactivated state, and neurotransmitter pools (GABA and glycine) within inhibitory interneurons undergo vesicular depletion. Analgesic efficacy breaks down rapidly within 15 to 20 minutes. Our platform overcomes synaptic exhaustion by executing continuous 80 Hz to 120 Hz frequency sweeps across a 4-second sinusoidal envelope. The changing pulse repetition rate alters the inter-spike arrival intervals at the dorsal horn, preventing axonal sodium channels from locking into an inactivated refractory state. Concurrently, inhibitory interneurons sustain balanced neurotransmitter exocytosis and reuptake cycles. Presynaptic gating over nociceptive T-cells remains continuously active across multi-hour wear, sustaining pain suppression without requiring the patient to continuously crank up the output amplitude.
Q: How does the soft-start compliance tracking circuit prevent painful electric shocks when the user transitions from sitting to standing, causing pelvic skin impedance shifts?
A: Postural shifts (transitioning from sitting to standing or bending over) induce dynamic mechanical strains in the lower abdominal wall. This mechanical movement alters the microscopic contact area between the hydrogel and the epidermis, causing transcutaneous load impedance to fluctuate between 600 Ohm and 2,200 Ohm in fractions of a second. In constant-voltage stimulators, an impedance dip triggers sudden Ohm's law current spikes (I = V / R), delivering sharp electrical shocks. Conversely, when users power on a device, an instantaneous current step induces reflex abdominal muscle flinching. Our console eliminates these hazards through a dual-stage regulation engine. First, whenever the unit activates or intensity is adjusted, a digital soft-start profile ramps current upward across a smooth 1.5-second gradient, conditioning sensory axons without startling the user. Second, during continuous operation, a 200 kHz current-sense loop monitors output current across precision shunts. When postural movement causes an impedance dip, the microcontroller modulates the boost stage duty cycle within 25 microseconds, scaling down the 80V compliance rail to clamp delivered current precisely to the user's dialed setting. If an edge peels significantly (dR/dt > 800Ωms), hardware comparator circuits shut off output within 15 microseconds, preventing current crowding and micro-arcing before the user can perceive a shock.
Women's health medical device brand directors, gynecological clinical procurement leads, and consumer wellness hardware operators can request complete ANSI/AAMI NS4 electrical compliance dossiers, dermatomal sweep oscillograms, and functional unbranded wearable evaluation units with custom butterfly hydrogel electrode kits.
👉 [Request Wearable Period Pain TENS Evaluation Kits]
Hot Tags: tens period pain relief, China tens period pain relief manufacturers, suppliers, factory, TENS Electro Stimulator, TENS Machines for Arthritis, Nerve Stimulation Machines, Transcutaneous Electrical Nerve Stimulation TENS Machines, electrical nerve stimulation TENS, TENS Neurostimulator
Specifications
|
Device name |
TENS-806 |
|
Power sources |
3.7 V Li-ion battery |
|
Power supply |
Input: 100-240V AC, 50/60Hz,0.2A; Output: 5V DC, 300mA |
|
Output channel |
Dual channel |
|
Waveform |
Bi-phase square-wave pulse |
|
Output current |
Max. 120mA (at 500ohm load) |
|
Output intensity |
0 to 40 levels, adjustable |
|
Treatment mode |
TENS,EMS |
|
Number of programs |
26 program |
|
Pulse rate |
2Hz ~ 120Hz |
|
Pulse width |
50uS ~ 300uS |
|
Treatment time |
5 minutes ~ 90 minutes |
|
Operating condition |
5° C to 40° C with a relative humidity of 15%-93%, |
|
Storage condition |
-10° C to 55° C with a relative humidity of 10%- |
|
Dimension |
109*55*18mm (L x W x T) |
|
Weight |
About 73g |
|
Automatic shutof |
1 minute |
|
Classification |
BF type applied part, internal power equipment, IP22 |
|
Size of electrodes pad |
40x40mm, square |
|
Output precision |
±20% error is allowed for all the output parameters |







